VIEW PRESS RELEASE 15 APR 2014: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today they will be using a $1.5M award from NIH to expand their Parkinson’s monitoring technology to mobile applications. Repositioning GLNT’s Kinesia™ product line with…
Blog Archives
PRESS RELEASE: $1.5M NIH Funding To Expand Parkinson’s Telemedicine To Mobile Apps
Tagged with: app, dbs, deep brain stimulation, fda, kinesia, mobile, nih, parkinson's disease, parkinson's telemedicine, remote, rigidity, sensor, telemedicine, therapy, tremor
PRESS RELEASE: Great Lakes NeuroTechnologies Continues Intellectual Property Growth As New Patent Claims Focus On Parkinson’s Device Accuracy And Sensitivity
VIEW PRESS RELEASE 05 MAR 2014: Valley View, OH – Great Lakes NeuroTechnologies announced today they have received a new allowance of claims from the U.S. Patent Office, the company’s fourth in the past eight months focused on technology for…
Tagged with: assessment, bradykinesia, clinical trials, company, dbs, deep brain stimulation, development, dyskinesia, gait, growth, kinesia, movement disorders, neuroprotective, parkinson's disease, patent, pd, rigidity, telemedicine, tremor
Clinician Versus Machine: Reliability and Responsiveness of Motor Endpoints in Parkinson’s Disease
D. Heldman, A. Espay, P. Lewitt, and J. Giuffrida Parkinsonism Relat Disord. 2014;20(6):590–5.
Tagged with: bradykinesia, endpoints, kinesia, parkinson's disease, pd, reliability, resposiveness, tremor, updrs
PRESS RELEASE: Scholarships from GLNT to Support Biomedical Engineering Education for Northeast Ohio Students
VIEW PRESS RELEASE 13 FEB 2014: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) is again sponsoring scholarship awards to promote and support biomedical engineering education. Two $1,000 scholarships are available to Northeast Ohio high school seniors interested in studying…
PRESS RELEASE: GLNT Secures Allowance Of Patent For Controlling Parkinson’s Therapy In Response To Symptoms
VIEW PRESS RELEASE [PDF] 04 FEB 2014: Valley View, OH – Great Lakes NeuroTechnologies announced today they have received another allowance of claims from the U.S. Patent Office. The application covers a system and method of controlling Parkinson’s therapy in…
PRESS RELEASE: Great Lakes NeuroTechnologies Launches Study to Automatically Classify Abnormal Muscle Tone in Movement Disorders
VIEW PRESS RELEASE [PDF] 15 JAN 2014: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today that it is launching a study to determine the feasibility of a clinician-worn glove to objectively evaluate abnormal muscle tone, such as stiff…
Tagged with: abnormal muscle tone, botox, cerebral palsy, cleveland clinic, clinical study, deep brain stimulation, diagnostic, dystonia, kinesia, motor impairment, muscle properties, neurological disorders, nih, ninds, objective assessment, parkinson's disease, ridigity, sbir grant, spasticity, spinal cord injury, stroke
Tradeshow Event: Partnership in Clinical Trials
The Mirage Hotel Las Vegas, NV March 31 – April 2 2014 Conference home page We will be exhibiting at booth #1305 . We will be demonstrating out Kinesia HomeView and ProView systems. From the 2013 event: This year’s event…
WKSU Exploradio: Measuring progress in Parkinson’s research
Sunday, November 10, 2013 WKSU’s Jeff St. Clair recently visited our offices and met with Dr. Dustin Heldman, Sr. BME Researcher, and Ms. Maureen Phillips, Sales Manager. The three had some great talks about alternative and innovatives therapies for Parkinson’s…
PRESS RELEASE: GLNT Awarded Patent For Sensor Based Continuous Parkinson’s Assessment During Daily Activities
VIEW PRESS RELEASE [PDF] 03 DEC 2013: Valley View, OH – Great Lakes NeuroTechnologies announced today they have received allowance of claims from the U.S. Patent Office for an application covering their system and method of continuous monitoring of motor…
PRESS RELEASE: GLNT Expanding Telemedicine Technology for Parkinson’s Disease
VIEW PRESS RELEASE [PDF] 05 Sept 2013: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today they are launching commercialization and clinical studies to expand their telemedicine technology, Kinesia HomeView™ [ http://glneurotech.com/kinesia/homeview/ ], for individuals with Parkinson’s disease by…